Inato

Kourosh Davarpanah is the CEO of Inato. To contact Kourosh Davarpanah email at [email protected] or [email protected]. Or you may call +33.682993224 or 347 654 0779

The decision makers in Inato are Alexandre Halley, Andrew Sutton, Bastien Duret, etc. Click to Find Inato decision makers emails.

You can reach out to Inato through their official website's contact form or by emailing their support team directly. For urgent inquiries, consider calling their main office number listed on the website for prompt assistance.

Inato does not publicly list a detailed staff directory. However, you can find key team members and their roles on the 'About Us' section of the website. For specific inquiries, use the general contact options provided.

Inato primarily supports the pharmaceutical and healthtech industries. Their innovative approach leverages AI and machine learning to enhance clinical trial feasibility and site selection, ensuring broader patient access and improved trial outcomes.

Yes, detailed information about Inato's clinical trial software, including its features and benefits, can be found on their website. The software is designed to optimize site selection and improve patient recruitment for clinical trials.

Inato focuses on diversifying clinical trial sites to include underrepresented populations. By utilizing advanced technology and data analytics, they identify and engage with sites that can reach a wider patient demographic, ensuring equitable access.

Inato employs a data-driven approach to feasibility, utilizing AI and machine learning to assess site capabilities and patient populations. This ensures that trials are not only scientifically sound but also accessible to the patients who need them.